BEVAZAME Trademark

Trademark Overview

On Tuesday, August 22, 2017, a trademark application was filed for BEVAZAME with the United States Patent and Trademark Office. The USPTO has given the BEVAZAME trademark a serial number of 87579144. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 8, 2021. This trademark is owned by Pfizer Inc.. The BEVAZAME trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of oncological diseases and disorders
bevazame

General Information

Serial Number87579144
Word MarkBEVAZAME
Filing DateTuesday, August 22, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 28, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, February 8, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 8, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 10, 2020EXTENSION 5 GRANTED
Thursday, May 28, 2020EXTENSION 5 FILED
Tuesday, June 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 28, 2020TEAS EXTENSION RECEIVED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019EXTENSION 4 GRANTED
Tuesday, December 17, 2019EXTENSION 4 FILED
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Wednesday, June 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2019EXTENSION 3 GRANTED
Monday, June 24, 2019EXTENSION 3 FILED
Monday, June 24, 2019TEAS EXTENSION RECEIVED
Wednesday, December 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 10, 2018EXTENSION 2 GRANTED
Monday, December 10, 2018EXTENSION 2 FILED
Monday, December 10, 2018TEAS EXTENSION RECEIVED
Saturday, June 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 7, 2018EXTENSION 1 GRANTED
Thursday, June 7, 2018EXTENSION 1 FILED
Thursday, June 7, 2018TEAS EXTENSION RECEIVED
Tuesday, January 2, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, September 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 16, 2017ASSIGNED TO EXAMINER
Monday, August 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 25, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

bevazame diseases disorders oncological treatment preparations substances pharmaceutical